Sfoglia per Rivista
Qualitative and quantitative polymerase chain reaction monitoring of minimal residual disease in relapsed chronic lymphocytic leukemia: early assessment can predict long-term outcome after reduced intensity allogeneic transplantation
2009 L., Farina; C., Carniti; A., Dodero; A., Vendramin; A., Raganato; F., Spina; F., Patriarca; Narni, Franco; F., Benedetti; A., Olivieri; P., Corradini
Quality of life assessment in elderly patients with aggressive non-Hodgkin's Lymphoma treated with anthracycline-containing regimens. Report of a prospective study by the Intergruppo Italiano Linfomi
2004 Merli, F; Bertini, M; Luminari, Stefano; Mozzana, R; Berte, R; Trottini, M; Stelitano, C; Botto, B; Pizzuti, M; Quintana, G; De Paoli, A; Federico, Massimo
A RANDOMIZED, DOUBLE-BLIND, CROSS-OVER STUDY COMPARING A LEVOSULPIRIDE-BASED AND A METOCLOPRAMIDE-BASED COMBINATION IN THE PREVENTION OF PROMECE-CYTABOM-INDUCED EMESIS
1995 Sabbatini, R; Federico, Massimo; Baldini, L; Barbieri, F; Maiolo, Mt; Silingardi, Vittorio
Reduced intensity conditioning with thiotepa, fludarabine and melphalan for allogeneic transplantation in multiple myeloma.
2003 I., Majolino; K. P., Urago; M., Riccardi; A., Locasciulli; A., Bacigalupo; P., Di Bartolomeo; R., Scimè; A., Olivieri; Narni, Franco; P., Corradini
Relationship between prognostic factors and therapy in high grade non Hodgkin's lymphomas over two decades
1989 Federico, Massimo; Gobbi, P. G.; Barbieri, F.; Silingardi, Vittorio
Reply to: [Efficacy of cyclosporine as a single agent therapy in chronic idiopathic thrombocytopenic purpura". Haematologica 2008; 93:e61]
2008 Emilia, G.; Luppi, M.; Morselli, M.; Forghieri, F.; Potenza, L.; Torelli, G.
Response to sequential treatment with lymphoblastoid interferon-α in patients with Ph+ chronic myeloid leukemia unresponsive to recombinant interferon-α (rIFNα2a) and neutralizing-rIFNα2a antibodies negative
1997 Russo, D.; Candoni, A.; Grattoni, R.; Minisini, R.; Rosti, G.
Restoring uptake and retention of daunorubicin and idarubicin in P170-related multidrug resistance cells by low concentration D-verapamil, cyclosporin-A and SDZ PSC 833
1994 Michieli, M.; Damiani, D.; Michelutti, A.; Candoni, A.; Masolini, P.; Scaggiante, B.; Quadrifoglio, F.; Baccarani, M.
Retrospective analysis of mantle cell lymphoma: experience of the Gruppo Italiano per lo Studio dei Linfomi (GISL)
1998 Callea, V; Clo, V; Morabito, F; Baldini, L; Stelitano, C; Narni, Franco; Avanzini, P; Brugiatelli, M; Silingardi, Vittorio
Risk assessment in diffuse large cell lymphoma at first relapse. A study by the Italian Intergroup for Lymphomas.
2001 Guglielmi, C.; Martelli, M.; Federico, Massimo; Zinzani, P. L.; Vitolo, U.; Bellesi, G.; Santini, G.; Tarella, C.; Zallio, F.; Pregno, P.; Di Renzo, N.; Resegotti, L.
Safety and efficacy of lenalidomide in combination with rituximab in recurrent indolent non-follicular lymphoma: Final results of a phase II study conducted by the Fondazione Italiana Linfomi
2016 Sacchi, Stefano; Marcheselli, Raffaella; Bari, Alessia; Buda, Gabriele; Molinari, Anna Lia; Baldini, Luca; Vallisa, Daniele; Cesaretti, Marina; Musto, Pellegrino; Ronconi, Sonia; Specchia, Giorgina; Silvestris, Franco; Guardigni, Luciano; Ferrari, Angela; Chiapella, Annalisa; Carella, Angelo Michele; Santoro, Armando; Di Raimondo, Francesco; Marcheselli, Luigi; Pozzi, Samantha
Sea-blue histiocytes in the bone marrow of a patient with Niemann-Pick disease type B
2001 Candoni, A.; Doretto, P.; Bembi, B.
SECOND MALIGNANCIES AFTER TREATMENT FOR INDOLENT LYMPHOMA: A 16 YEARS FOLLOW-UP STUDY
2007 Sacchi, Stefano; Marcheselli, Luigi; Bari, Alessia; Marcheselli, Raffaella; Pozzi, Samantha; Luminari, Stefano; M., Lombardo; G., Buda; A., Lazzaro; P., Gobbi; C., Stelitano; M., Brugiatelli
Second malignancies after treatment of diffuse large B-cell non-Hodgkin's lymphoma: a GISL cohort study
2008 Sacchi, Stefano; Marcheselli, Luigi; Bari, Alessia; Marcheselli, Raffaella; Pozzi, Samantha; Gobbi, Pg; Angrilli, F; Brugiatelli, M; Musto, P; Federico, Massimo
Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: A 16-year follow-up study
2008 Sacchi, Stefano; Marcheselli, Luigi; Bari, Alessia; Marcheselli, Raffaella; Pozzi, Samantha; Luminari, Stefano; Lombardo, M; Buda, G; Lazzaro, A; Gobbi, Pg; Stelitano, C; Morabito, F; Quarta, G; Brugiatelli, M.
Secondary malignant neoplasms, progression-free survival and overall survival in patients treated for Hodgkin lymphoma: A systematic review and meta-analysis of randomized clinical trials
2017 Eichenauer, Dennis A.; Becker, Ingrid; Monsef, Ina; Chadwick, Nicholas; De Sanctis, Vitaliana; Federico, Massimo; Fortpied, Catherine; Gianni, Alessandro M.; Henry-Amar, Michel; Hoskin, Peter; Johnson, Peter; Luminari, Stefano; Bellei, Monica; Pulsoni, Alessandro; Sydes, Matthew R.; Valagussa, Pinuccia; Viviani, Simonetta; Engert, Andreas; Franklin, Jeremy
Selenium and lymphoid malignancies (Reply)
1997 Avanzini, P; Vinceti, M; Ilariucci, F
Selenium status in the body of proliferative activity of malignant cells
1997 Piccinini, Lino; Borella, Paola; Bargellini, Annalisa
A sequential approach with imatinib, chemotherapy and transplant for adult Ph+ acute lymphoblastic leukemia. Final results of the GIMEMA LAL 0904 study
2016 Chiaretti, Sabina; Vitale, Antonella; Vignetti, Marco; Piciocchi, Alfonso; Fazi, Paola; Elia, Loredana; Falini, Brunangelo; Ronco, Francesca; Ferrara, Felicetto; De Fabritiis, Paolo; Luppi, Mario; La Nasa, Giorgio; Tedeschi, Alessandra; Califano, Catello; Fanin, Renato; Dore, Fausto; Mandelli, Franco; Meloni, Giovanna; Foa', Robin
A SEQUENTIAL USE OF TKI, CHEMOTHERAPY AND TRANSPLANT IS ASSOCIATED WITH HIGH COMPLETE REMISSION RATES, DISEASE-FREE AND OVERALL SURVIVAL IN ADULT PH+ ALL. RESULTS OF THE GIMEMA 0904 PROTOCOL
2013 S. Chiaretti, A. Vitale; Piciocchi, Al; Fazi, P; Falzetti, F; Nobile, F; Ferrara, F; Luppi, Mario; Nasa, G. La; Fabritiis, P. de; Tedeschi, A; D’Arco, A. Maria; Fanin, R; Fozza, C; Meloni, G; Negulici, A; Propriis, M. De; Guarini, A; Elia, L; Vignetti, M.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Qualitative and quantitative polymerase chain reaction monitoring of minimal residual disease in relapsed chronic lymphocytic leukemia: early assessment can predict long-term outcome after reduced intensity allogeneic transplantation | 1-gen-2009 | L., Farina; C., Carniti; A., Dodero; A., Vendramin; A., Raganato; F., Spina; F., Patriarca; Narni, Franco; F., Benedetti; A., Olivieri; P., Corradini | |
Quality of life assessment in elderly patients with aggressive non-Hodgkin's Lymphoma treated with anthracycline-containing regimens. Report of a prospective study by the Intergruppo Italiano Linfomi | 1-gen-2004 | Merli, F; Bertini, M; Luminari, Stefano; Mozzana, R; Berte, R; Trottini, M; Stelitano, C; Botto, B; Pizzuti, M; Quintana, G; De Paoli, A; Federico, Massimo | |
A RANDOMIZED, DOUBLE-BLIND, CROSS-OVER STUDY COMPARING A LEVOSULPIRIDE-BASED AND A METOCLOPRAMIDE-BASED COMBINATION IN THE PREVENTION OF PROMECE-CYTABOM-INDUCED EMESIS | 1-gen-1995 | Sabbatini, R; Federico, Massimo; Baldini, L; Barbieri, F; Maiolo, Mt; Silingardi, Vittorio | |
Reduced intensity conditioning with thiotepa, fludarabine and melphalan for allogeneic transplantation in multiple myeloma. | 1-gen-2003 | I., Majolino; K. P., Urago; M., Riccardi; A., Locasciulli; A., Bacigalupo; P., Di Bartolomeo; R., Scimè; A., Olivieri; Narni, Franco; P., Corradini | |
Relationship between prognostic factors and therapy in high grade non Hodgkin's lymphomas over two decades | 1-gen-1989 | Federico, Massimo; Gobbi, P. G.; Barbieri, F.; Silingardi, Vittorio | |
Reply to: [Efficacy of cyclosporine as a single agent therapy in chronic idiopathic thrombocytopenic purpura". Haematologica 2008; 93:e61] | 1-gen-2008 | Emilia, G.; Luppi, M.; Morselli, M.; Forghieri, F.; Potenza, L.; Torelli, G. | |
Response to sequential treatment with lymphoblastoid interferon-α in patients with Ph+ chronic myeloid leukemia unresponsive to recombinant interferon-α (rIFNα2a) and neutralizing-rIFNα2a antibodies negative | 1-gen-1997 | Russo, D.; Candoni, A.; Grattoni, R.; Minisini, R.; Rosti, G. | |
Restoring uptake and retention of daunorubicin and idarubicin in P170-related multidrug resistance cells by low concentration D-verapamil, cyclosporin-A and SDZ PSC 833 | 1-gen-1994 | Michieli, M.; Damiani, D.; Michelutti, A.; Candoni, A.; Masolini, P.; Scaggiante, B.; Quadrifoglio, F.; Baccarani, M. | |
Retrospective analysis of mantle cell lymphoma: experience of the Gruppo Italiano per lo Studio dei Linfomi (GISL) | 1-gen-1998 | Callea, V; Clo, V; Morabito, F; Baldini, L; Stelitano, C; Narni, Franco; Avanzini, P; Brugiatelli, M; Silingardi, Vittorio | |
Risk assessment in diffuse large cell lymphoma at first relapse. A study by the Italian Intergroup for Lymphomas. | 1-gen-2001 | Guglielmi, C.; Martelli, M.; Federico, Massimo; Zinzani, P. L.; Vitolo, U.; Bellesi, G.; Santini, G.; Tarella, C.; Zallio, F.; Pregno, P.; Di Renzo, N.; Resegotti, L. | |
Safety and efficacy of lenalidomide in combination with rituximab in recurrent indolent non-follicular lymphoma: Final results of a phase II study conducted by the Fondazione Italiana Linfomi | 1-gen-2016 | Sacchi, Stefano; Marcheselli, Raffaella; Bari, Alessia; Buda, Gabriele; Molinari, Anna Lia; Baldini, Luca; Vallisa, Daniele; Cesaretti, Marina; Musto, Pellegrino; Ronconi, Sonia; Specchia, Giorgina; Silvestris, Franco; Guardigni, Luciano; Ferrari, Angela; Chiapella, Annalisa; Carella, Angelo Michele; Santoro, Armando; Di Raimondo, Francesco; Marcheselli, Luigi; Pozzi, Samantha | |
Sea-blue histiocytes in the bone marrow of a patient with Niemann-Pick disease type B | 1-gen-2001 | Candoni, A.; Doretto, P.; Bembi, B. | |
SECOND MALIGNANCIES AFTER TREATMENT FOR INDOLENT LYMPHOMA: A 16 YEARS FOLLOW-UP STUDY | 1-gen-2007 | Sacchi, Stefano; Marcheselli, Luigi; Bari, Alessia; Marcheselli, Raffaella; Pozzi, Samantha; Luminari, Stefano; M., Lombardo; G., Buda; A., Lazzaro; P., Gobbi; C., Stelitano; M., Brugiatelli | |
Second malignancies after treatment of diffuse large B-cell non-Hodgkin's lymphoma: a GISL cohort study | 1-gen-2008 | Sacchi, Stefano; Marcheselli, Luigi; Bari, Alessia; Marcheselli, Raffaella; Pozzi, Samantha; Gobbi, Pg; Angrilli, F; Brugiatelli, M; Musto, P; Federico, Massimo | |
Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: A 16-year follow-up study | 1-gen-2008 | Sacchi, Stefano; Marcheselli, Luigi; Bari, Alessia; Marcheselli, Raffaella; Pozzi, Samantha; Luminari, Stefano; Lombardo, M; Buda, G; Lazzaro, A; Gobbi, Pg; Stelitano, C; Morabito, F; Quarta, G; Brugiatelli, M. | |
Secondary malignant neoplasms, progression-free survival and overall survival in patients treated for Hodgkin lymphoma: A systematic review and meta-analysis of randomized clinical trials | 1-gen-2017 | Eichenauer, Dennis A.; Becker, Ingrid; Monsef, Ina; Chadwick, Nicholas; De Sanctis, Vitaliana; Federico, Massimo; Fortpied, Catherine; Gianni, Alessandro M.; Henry-Amar, Michel; Hoskin, Peter; Johnson, Peter; Luminari, Stefano; Bellei, Monica; Pulsoni, Alessandro; Sydes, Matthew R.; Valagussa, Pinuccia; Viviani, Simonetta; Engert, Andreas; Franklin, Jeremy | |
Selenium and lymphoid malignancies (Reply) | 1-gen-1997 | Avanzini, P; Vinceti, M; Ilariucci, F | |
Selenium status in the body of proliferative activity of malignant cells | 1-gen-1997 | Piccinini, Lino; Borella, Paola; Bargellini, Annalisa | |
A sequential approach with imatinib, chemotherapy and transplant for adult Ph+ acute lymphoblastic leukemia. Final results of the GIMEMA LAL 0904 study | 1-gen-2016 | Chiaretti, Sabina; Vitale, Antonella; Vignetti, Marco; Piciocchi, Alfonso; Fazi, Paola; Elia, Loredana; Falini, Brunangelo; Ronco, Francesca; Ferrara, Felicetto; De Fabritiis, Paolo; Luppi, Mario; La Nasa, Giorgio; Tedeschi, Alessandra; Califano, Catello; Fanin, Renato; Dore, Fausto; Mandelli, Franco; Meloni, Giovanna; Foa', Robin | |
A SEQUENTIAL USE OF TKI, CHEMOTHERAPY AND TRANSPLANT IS ASSOCIATED WITH HIGH COMPLETE REMISSION RATES, DISEASE-FREE AND OVERALL SURVIVAL IN ADULT PH+ ALL. RESULTS OF THE GIMEMA 0904 PROTOCOL | 1-gen-2013 | S. Chiaretti, A. Vitale; Piciocchi, Al; Fazi, P; Falzetti, F; Nobile, F; Ferrara, F; Luppi, Mario; Nasa, G. La; Fabritiis, P. de; Tedeschi, A; D’Arco, A. Maria; Fanin, R; Fozza, C; Meloni, G; Negulici, A; Propriis, M. De; Guarini, A; Elia, L; Vignetti, M. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile